New classification system-based visual outcome in Eales' disease. Indian J Ophthalmol.
Long-Term Outcomes of a Large Cohort of Patients with Eales' Disease. Ocul Immunol Inflamm.
Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales' disease. J Ocul Biol Dis Infor.
Spontaneous relief of vitreomacular traction and regression of neovascularization in Eales' disease after intravitreal injection of bevacizumab.
Role of intravitreal bevacizumab in Eales' disease with dense vitreous hemorrhage: a prospective randomized control study.
Out of 52 eyes injected, 29 had diabetic retinopathy with clinically significant macular oedema, 11 had choroidal neovascularization, 4 had cental retinal vein occlusion, 5 had branch retinal vein occlusion, 2 were suffering from Eales' disease
and one patient has a pigment epithelial detachment.
Background & objectives: Eales' disease is an idiopathic disease resulting in retinal neovascularization, recurrent haemorrhages, with or without retinal detachment predominantly affecting healthy young males (97.6%) in the Indian subcontinent.
in the aetiopathogenesis of Eales' disease. Further studies on a larger sample will be required to confirm these findings.
Eales' disease is an idiopathic disease with retinal perivasculitis predominantly affecting the peripheral retina during the inflammatory stage followed by sclerosis of the retinal veins and retinal ischaemia and finally, retinal or optic disk neovascularization, recurrent haemorrhages, with or without retinal detachment (1).
Patients: Patients included in this study were those clinically diagnosed as Eales' disease by the criteria described by Das et al (1) and non-Eales' patients with non-infective diseases such as proliferative diabetic retinopathy, retinal detachment and proliferative vitreoretinopathy as controls.
Of these, 20 were from patients clinically diagnosed as Eales' disease and 13 others were from non-Eales' patients Group Ia.